tyrosine has been researched along with Recrudescence in 72 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.94) | 18.7374 |
| 1990's | 15 (20.83) | 18.2507 |
| 2000's | 31 (43.06) | 29.6817 |
| 2010's | 17 (23.61) | 24.3611 |
| 2020's | 4 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikari, A; Adhikari, S; Allen, JR; Alpert, EJ; Do, D; Gallagher, K; Garcia, SP; Heckman, CA; Heinäniemi, M; Hyvärinen, N; Iyer, S; Jin, AH; Kelliher, M; Langenau, DM; Laukkanen, S; Lohi, O; Loontiens, S; McCarthy, K; Moisio, S; Oksa, L; Pello, A; Ruokoranta, T; Veloso, A; Whelton, L; Yan, C; Yang, Q; Yoder, JA | 1 |
| Carda-Diéguez, M; Cooksley, C; Crosby, HA; Horswill, AR; Kidd, SP; Lee, J; Mira, A; Vreugde, S; Žiemytė, M; Zilm, PS | 1 |
| Chen, J; Li, C; Sun, H; Sun, L; Wang, J; Xiao, H; Zhang, L | 1 |
| Bourhis, D; Dissaux, B; Dissaux, G; Querellou, S; Schick, U | 1 |
| Fellner, FA; Gabriel, M; Hatzl, M; Röper-Kelmayr, JC | 1 |
| Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W | 1 |
| Blaum, M; Galldiks, N; Heinzel, A; Langen, KJ; Mottaghy, FM; Müller, D; Verburg, FA | 1 |
| Baik, SK; Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Park, SP | 1 |
| Akpek, M; Arinc, H; Baktir, AO; Ergin, A; Kaya, MG; Oguzhan, A; Saglam, H; Sahin, O; Sarli, B; Urkmez, S | 1 |
| Bluemel, C; Buck, AK; Czernin, J; Ernestus, RI; Herrmann, K; Homola, GA; Kessler, AF; Lapa, C; Linsenmann, T; Löhr, M; Monoranu, CM; Samnick, S | 1 |
| Bolcaen, J; Boterberg, T; De Vos Pharm, F; Deblaere, K; Decrock, E; Descamps, B; Goethals, I; Kalala, JP; Leybaert, L; Van den Broecke, C; Vanhove, C | 1 |
| Andersen, SB; Bøgeskov, L; Cleff, C; Coenen, HH; Dunkl, V; Fink, GR; Galldiks, N; Judov, N; Langen, KJ; Law, I; Nysom, K; Reifenberger, G; Sarikaya-Seiwert, S; Shah, NJ; Steiger, HJ; Stoffels, G | 1 |
| Chen, L; Gui, B; Qin, G; Wu, B; Xie, J; Zhou, J | 1 |
| Hwang, YH; Kang, DH; Kim, YS; Kim, YW; Liebeskind, DS | 1 |
| Borklu, EB; Cinier, G; Eren, M; Hayiroglu, MI; Kaya, A; Keskin, M; Tatlisu, MA; Uzman, O | 1 |
| Abualhaj, B; Attarwala, AA; Büsing, K; Glatting, G; Molina, F; Ong, M; Weng, G | 1 |
| Barbieri, M; Caporaso, I; D'Amico, F; Marfella, R; Paolisso, G; Paolisso, P; Rizzo, MR; Sacra, C; Santamaria, M; Santulli, G; Sardu, C; Testa, N | 1 |
| Braun-Dullaeus, RC; Hass, N; Ibrahim, K; Kolschmann, S; Strasser, RH | 1 |
| De Boer, MJ; Dill, T; Gosselink, AT; Hamm, C; Heestermans, AA; Hoorntje, JC; Koopmans, PC; Ten Berg, JM; Van 't Hof, AW; Van Houwelingen, G; Van Werkum, JW | 1 |
| Bates, ER; Chetcuti, S; Grossman, PM; Gurm, HS; Meier, P; Tamhane, U | 1 |
| Auf, G; Blechschmidt, C; Brenner, W; Denecke, T; Geworski, L; Nyuyki, F; Plotkin, M; Stockhammer, F | 1 |
| Anselmi, M; Bolognese, L; Bressers, M; Bristot, L; Campo, G; Colangelo, S; De Cesare, N; Gambetti, S; Garcia-Garcia, HM; Garg, S; Monti, M; Moreno, R; Parrinello, G; Rodriguez, AE; Sarno, G; Serruys, PW; Valgimigli, M | 1 |
| Comhair, SA; DiDonato, JA; Erzurum, SC; Hazen, SL; McDowell, KM; Wedes, SH; Wu, W | 1 |
| Bolognese, L; Bramucci, E; Campo, G; Colangelo, S; Corrada, E; De Cesare, N; E Rodriguez, A; Ferrante, G; Ferrari, R; Moreno, R; Nazzaro, MS; Pasquetto, G; Piva, T; Prati, F; Presbitero, P; Sheiban, I; Valgimigli, M; Vassanelli, C | 1 |
| Kang, BH; Lin, YS; Su, WF; Wang, HW | 1 |
| Kurup, PA; Kurup, RK | 1 |
| Ambrosini, V; Battaglia, S; Cioppa, A; Lo Muzio, L; Rubino, P; Salemme, L; Sorropago, G; Tesoria, T | 1 |
| Bates, TE; Bella, R; Calabrese, V; Foresti, R; Giuffrida Stella, AM; Pennisi, G; Ravagna, A; Scapagnini, G | 1 |
| Antman, EM; Sabatine, MS | 1 |
| Briesewitz, R; Bruner, RJ; Caligiuri, MA; Griffin, JH; Leung, J | 1 |
| Dambrink, JH; de Boer, MJ; de Vries, ST; Gosselink, AT; Hoorntje, JC; Miedema, K; Suryapranata, H; van 't Hof, AW; Zijlstra, F | 1 |
| Chang, HW; Chen, MC; Chen, SM; Fang, CY; Hsieh, YK; Wu, CJ; Yip, HK | 1 |
| Bigonzi, F; Cohen, M; Danchin, N; Gensini, GF; Gurfinkel, EP; Hecquet, C; Huber, K; Krzeminska-Pakula, M; Maritz, F; Santopinto, J; Timerman, A; Vittori, L; White, HD | 1 |
| Bousquet, B; Garnier, JP; Ghanem, G; Le Bricon, T; Letellier, S; Morel, P; Stoitchkov, K; Tsankov, N | 1 |
| Antman, EM; Braunwald, E; Cannon, CP; Demopoulos, LA; DiBattiste, PM; Giugliano, RP; McCabe, CH; Morrow, DA; Murphy, SA; Sabatine, MS; Weintraub, WS | 1 |
| Bolton, ED; Braunstein, JB; Chiles, KA; Faraday, N; Gerstenblith, G; Heldman, AW; Schulman, SP | 1 |
| Deng, Y; Fan, Y; Huang, WH | 1 |
| Bertagnolli, MM; Carothers, AM; Hunt, DH; Javid, SH; Moran, AE; Redston, M | 1 |
| Earp, HS; Fei, X; French, FS; Gregory, CW; Liu, Y; McCall, W; Ponguta, LA; Whang, YE; Wilson, EM | 1 |
| Chen, SM; Fang, CY; Fu, M; Guo, GB; Hsieh, YK; Wu, CJ; Yip, HK | 1 |
| Antoni, D; Creed, J; Greeley, W; Pastuszko, A; Schears, G; Wilson, DF; Zaitseva, T | 1 |
| Cakir, N; Midilli, K; Pamuk, ON; Umit, H | 1 |
| Agnantis, NJ; Bai, M; Galaris, D; Gloustianou, G; Katsouras, C; Malamou-Mitsi, VD; Michalis, LK; Sideris, DA; Toumpoulis, IK; Vardakas, D | 1 |
| Buescher, ES; Gaither, T; Gallin, JI; Katz, P; Nath, J; Seligmann, BE | 1 |
| Ogawa, H; Takada, A; Takada, Y; Yamazaki, Y | 1 |
| Amatniak, AG; Geller, LI; Kazimirchuk, AP | 1 |
| Go, KG; Luurtsema, G; Paans, AM; Pruim, J; Vaalburg, W; van Waarde, A; Willemsen, AT | 1 |
| Ceccherini, I; Elisei, R; Mancusi, F; Martino, E; Molinaro, E; Pacini, F; Pinchera, A; Romei, C; Romeo, G | 1 |
| Tcheng, JE | 2 |
| Cross, AH; Manning, PT; Misko, TP; Stern, MK | 1 |
| Moliterno, DJ; Steinhubl, SR | 1 |
| Rossi, G | 1 |
| Abe, J; Deguchi, J; Hara, K; Ikari, Y; Kurokawa, K; Ohno, M; Takuwa, Y; Tamura, T | 1 |
| Cohen, DJ; Deckelbaum, LI; Gibson, CM; Goel, M; Harris, KE; King, SB; Piana, RN | 1 |
| Cross, AH; Keeling, RM; Manning, PT; Misko, TP; Schmidt, RE | 1 |
| Braunwald, E; Cannon, CP; Demopoulos, LA; Gormley, GJ; Robertson, DH; Weintraub, WS | 1 |
| Greenbaum, AB; Harrington, RA; Hudson, MP; Ohman, EM | 1 |
| Hansson, GK; Henderson, AM; Hunter, GC; Kobayashi, H; Putnam, CW; Sirsjo, A; Suzuki, F; Westerband, A; Yan, ZQ | 1 |
| Boccuzzi, SJ; Burnette, J; Cohen, DJ; Cook, JR; Culler, S; Kosinski, AS; Weintraub, WS | 1 |
| Banai, S; Chorny, M; Fishbein, I; Gazit, A; Gertz, SD; Golomb, G; Huber, R; Levitzki, A; Mayr, U; Rabinovich, L; Waltenberger, J | 1 |
| Califf, RM; Lincoff, AM; Topol, EJ | 1 |
| Deckelbaum, LI; Dodge, JT; Dotani, I; Gibson, CM; Goel, M; King, SB; Marble, SJ; Murphy, SA | 1 |
| Bigonzi, F; Cohen, M; Danchin, N; Fox, KA; Gensini, GF; Gurfinkel, EP; Huber, K; Le-Louer, V; Maritz, F; Timerman, A; Vittori, L; White, H | 1 |
| Berkowitz, SD | 1 |
| Jang, IK; Januzzi, JL; Sabatine, MS; Snapinn, S; Théroux, P | 1 |
| Becker, RC; Denier, D; Gouveia, W; Kimmelstiel, C; MacIsaac, DA; Miele, R; Phang, R; Rand, W; Rehman, A; Rhofiry, J | 1 |
| Goto, K; Ikemoto, S; Yui, K | 1 |
| Lewis, MJ; Margules, DL | 1 |
| Horii, I; Kudoh, K; Kuramoto, Y; Saijo, S; Tagami, H | 1 |
| Furtseva, LN; Gerasimov, AM; Kaz'min, AI; Toporov, AIu; Toporova, SM | 1 |
| Cammisuli, S; Feurer, C; Honegger, CG; Krenger, W | 1 |
9 review(s) available for tyrosine and Recrudescence
| Article | Year |
|---|---|
A comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Eptifibatide; Female; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2009 |
The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction.
Topics: Acute Disease; Angina, Unstable; Anticoagulants; Drug Therapy, Combination; Heparin; Humans; Logistic Models; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Recurrence; Risk Assessment; Thrombolytic Therapy; Tirofiban; Troponin; Tyrosine | 2003 |
NIH conference. Recent advances in chronic granulomatous disease.
Topics: Adolescent; Adult; Antibody-Dependent Cell Cytotoxicity; Child; Child, Preschool; Female; Granulomatous Disease, Chronic; Humans; Inflammation; Male; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Oxidation-Reduction; Pedigree; Phagocytes; Receptors, Complement; Receptors, Complement 3b; Recurrence; Tubulin; Tyrosine | 1983 |
Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Constriction, Pathologic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Stents; Tirofiban; Treatment Outcome; Tyrosine | 1996 |
Glycoprotein IIb/IIIa receptor antagonists for the treatment of unstable angina.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Clinical Trials as Topic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Tirofiban; Treatment Outcome; Tyrosine | 1997 |
Use of glycoprotein IIb/IIIa inhibition plus fibrinolysis in acute myocardial infarction.
Topics: Abciximab; Acetates; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Eptifibatide; Fibrinogen; Fibrinolytic Agents; Forecasting; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Pilot Projects; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Tyrosine | 1999 |
Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: bleeding, reversal, thrombocytopenia, and retreatment.
Topics: Eptifibatide; Hemorrhage; Humans; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Risk Factors; Survival Rate; Thrombocytopenia; Tirofiban; Tyrosine | 2000 |
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Combined Modality Therapy; Coronary Disease; Drug Monitoring; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Recurrence; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Drug Approval; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Myocardial Ischemia; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Recurrence; Safety; Single-Blind Method; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine; United States; United States Food and Drug Administration | 2000 |
15 trial(s) available for tyrosine and Recrudescence
| Article | Year |
|---|---|
Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Topics: Aged; Coronary Circulation; Coronary Thrombosis; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Time Factors; Tirofiban; Treatment Outcome; Turkey; Tyrosine | 2015 |
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation.
Topics: Aged; Antioxidants; Atrial Fibrillation; Biomarkers; Blood Glucose; C-Reactive Protein; Catheter Ablation; Cholesterol, HDL; Cholesterol, LDL; Cytokines; Double-Blind Method; Female; Humans; Interleukin-10; Interleukin-6; Interleukin-8; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peroxynitrous Acid; Postoperative Care; Recurrence; Thioctic Acid; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha; Tyrosine | 2017 |
Marked reduction of early stent thrombosis with pre-hospital initiation of high-dose Tirofiban in ST-segment elevation myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Emergency Medical Services; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Stents; Thrombolytic Therapy; Ticlopidine; Tirofiban; Tyrosine | 2009 |
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arrhythmias, Cardiac; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Italy; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Sex Factors; Sirolimus; Tirofiban; Tyrosine | 2012 |
Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.
Topics: Adult; Blotting, Western; Catalase; Cerebrospinal Fluid Proteins; Female; Glutathione; Glutathione Disulfide; Humans; Male; Middle Aged; Multiple Sclerosis; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peroxynitrous Acid; Recurrence; Reference Values; S-Nitrosothiols; Tyrosine | 2002 |
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes.
Topics: Angina, Unstable; Coronary Angiography; Death, Sudden, Cardiac; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Impact of tirofiban on angiographic morphologic features of high-burden thrombus formation during direct percutaneous coronary intervention and short-term outcomes.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Circulation; Coronary Thrombosis; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIb-IX Complex; Premedication; Recurrence; Stents; Survival Rate; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial
Topics: Administration, Oral; Aspirin; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Incidence; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Time Factors; Tirofiban; Tyrosine | 2003 |
Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Aged; Angina, Unstable; Arachidonic Acid; Aspirin; Blood Platelets; C-Reactive Protein; Cell Aggregation; Drug Resistance; Eptifibatide; Female; Heparin; Humans; Leukocytes; Male; Middle Aged; Monocytes; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Neutrophils; Patient Selection; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Receptors, Thrombin; Recurrence; ROC Curve; Tirofiban; Treatment Outcome; Troponin I; Tyrosine | 2004 |
Angiographic and clinical outcome in ST-segment elevation myocardial infarction patients receiving an adjunctive double bolus regimen of tirofiban for primary percutaneous coronary intervention.
Topics: Aged; Angiography; Angioplasty, Balloon, Coronary; Female; Hemorrhage; Humans; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Recurrence; Tirofiban; Treatment Outcome; Tyrosine | 2006 |
Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recurrence; Reoperation; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Th
Topics: Adolescent; Angina, Unstable; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Artery Bypass; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Research Design; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Combined Modality Therapy; Coronary Disease; Cost-Benefit Analysis; Double-Blind Method; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Retreatment; Risk Factors; Tirofiban; Tyrosine; United States | 1999 |
Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy). Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.
Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Collateral Circulation; Confidence Intervals; Coronary Circulation; Coronary Disease; Coronary Vessels; Double-Blind Method; Fibrinolytic Agents; Humans; Multivariate Analysis; Myocardial Infarction; Placebos; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Stents; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
The TETAMI trial: the safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and of tirofiban versus placebo in the treatment of acute myocardial infarction for patients not thrombolyzed: methods and design.
Topics: Adult; Aged; Clinical Protocols; Drug Therapy, Combination; Enoxaparin; Female; Fibrinolytic Agents; Heparin; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Placebos; Platelet Glycoprotein GPIIb-IIIa Complex; Recurrence; Survival Rate; Tirofiban; Tyrosine | 2000 |
48 other study(ies) available for tyrosine and Recrudescence
| Article | Year |
|---|---|
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Topics: Animals; Cell Line, Tumor; Child; Dasatinib; Humans; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mammals; Mechanistic Target of Rapamycin Complex 1; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptors, Antigen, T-Cell; Recurrence; Signal Transduction; T-Lymphocytes; Tyrosine; Zebrafish | 2022 |
Functional
Topics: Anti-Bacterial Agents; DNA; Humans; Recombinases; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Transcription Factors; Tyrosine | 2022 |
Activation of Tyrosine Metabolism in CD13+ Cancer Stem Cells Drives Relapse in Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; CD13 Antigens; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplastic Stem Cells; Recurrence; Tyrosine | 2020 |
18F-FET PET/CT in Early Subventricular Zone Recurrence of Adult Glioblastoma.
Topics: Adult; Brain Neoplasms; Female; Glioblastoma; Humans; Lateral Ventricles; Positron Emission Tomography Computed Tomography; Recurrence; Tyrosine | 2021 |
18F-Fluorocholine, 18F-FDG, and 18F-Fluoroethyl Tyrosine PET/CT in Parathyroid Cancer.
Topics: Aged; Choline; Female; Fluorodeoxyglucose F18; Humans; Parathyroid Neoplasms; Positron Emission Tomography Computed Tomography; Recurrence; Thyroidectomy; Tyrosine | 2017 |
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine | 2017 |
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Brain Neoplasms; Camptothecin; Cost-Benefit Analysis; Decision Trees; Disease-Free Survival; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Monte Carlo Method; Neoplasm Grading; Positron-Emission Tomography; Recurrence; Treatment Outcome; Tyrosine | 2013 |
Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Stroke; Thrombectomy; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2014 |
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Basal Ganglia; Biopsy; Brain; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Logistic Models; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Recurrence; Tyrosine | 2014 |
(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Choline; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glioblastoma; Necrosis; Neoplasm Grading; Positron-Emission Tomography; Radiation Injuries; Radioactive Tracers; Radiopharmaceuticals; Rats; Recurrence; Tyrosine | 2015 |
The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.
Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Humans; Infant; Male; Neoplasm, Residual; Positron-Emission Tomography; Recurrence; Sensitivity and Specificity; Tyrosine | 2015 |
PTEN inhibition preserves trigeminal nucleus caudalis neuron activation through tyrosine phosphorylation of the NR2B subunit at Tyr1472 of the NMDA receptor in a rat model of recurrent migraine.
Topics: Adenoviridae; Animals; Disease Models, Animal; Gene Expression Regulation; Male; Migraine Disorders; Neurons; Pain Measurement; Pain Threshold; Phosphopyruvate Hydratase; Phosphorylation; Proto-Oncogene Proteins c-fos; PTEN Phosphohydrolase; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recurrence; RNA, Small Interfering; Trigeminal Nuclei; Tyrosine | 2016 |
Impact of Target Arterial Residual Stenosis on Outcome After Endovascular Revascularization.
Topics: Aged; Cerebral Angiography; Combined Modality Therapy; Computed Tomography Angiography; Diagnosis, Differential; Endovascular Procedures; Female; Humans; Infarction, Middle Cerebral Artery; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Male; Middle Aged; Prevalence; Recurrence; Retrospective Studies; Risk Factors; Smoking; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine; Vasospasm, Intracranial | 2016 |
The association of the coronary thrombus burden with all-cause mortality and major cardiac events in ST-segment elevation myocardial infarction patients treated with tirofiban.
Topics: Aged; Cause of Death; Coronary Thrombosis; Female; Hemorrhage; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2016 |
Comparison of five cluster validity indices performance in brain [
Topics: Algorithms; Brain; Diagnosis, Differential; Glioma; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography; Recurrence; Reproducibility of Results; Tyrosine | 2017 |
Reversible clopidogrel resistance due to right ventricular myocardial infarction: risk factor of recurrent stent thrombosis?
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Drug-Eluting Stents; Electrocardiography; Enoxaparin; Fibrinolytic Agents; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Ticlopidine; Time Factors; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Right | 2008 |
Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas.
Topics: Adult; Aged; Biopsy; Brain Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Recurrence; Treatment Outcome; Tyrosine | 2010 |
Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolim
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Cardiovascular Agents; Coronary Angiography; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Immunoglobulin Fab Fragments; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Predictive Value of Tests; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Sirolimus; Stents; Thrombosis; Time Factors; Tirofiban; Treatment Outcome; Tyrosine | 2011 |
Urinary bromotyrosine measures asthma control and predicts asthma exacerbations in children.
Topics: Adolescent; Asthma; Biomarkers; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Follow-Up Studies; Forced Expiratory Flow Rates; Humans; Male; Predictive Value of Tests; Prognosis; Prospective Studies; Recurrence; Spirometry; Time Factors; Tyrosine; Young Adult | 2011 |
Immunolocalization of inducible nitric oxide synthase and 3-nitrotyrosine in recurrently inflamed, human palatine tonsils.
Topics: Humans; Immunohistochemistry; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Palatine Tonsil; Peroxynitrous Acid; Recurrence; Tonsillitis; Tyrosine | 2002 |
Hypothalamic digoxin, hemispheric dominance, and neuroimmune integration.
Topics: Creutzfeldt-Jakob Syndrome; Digoxin; Dolichols; Erythrocyte Membrane; Functional Laterality; Glycosaminoglycans; Humans; Hydroxymethylglutaryl CoA Reductases; Hypothalamus; Lupus Erythematosus, Systemic; Mental Disorders; Neuroimmunomodulation; Recurrence; Respiratory Tract Diseases; Sodium-Potassium-Exchanging ATPase; Subacute Sclerosing Panencephalitis; Tryptophan; Tyrosine; Ubiquinone | 2002 |
Percutaneous femoral artery angioplasty with stent-in-stent technique and tirofiban administration.
Topics: Angioplasty, Balloon; Female; Femoral Artery; Fibrinolytic Agents; Humans; Middle Aged; Recurrence; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome.
Topics: Adult; Amino Acid Sequence; Animals; Antineoplastic Agents; Base Sequence; Benzamides; Blotting, Western; Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Gene Deletion; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Indoles; Male; Mice; Models, Chemical; Models, Genetic; Molecular Sequence Data; Peptides; Phthalazines; Piperazines; Precipitin Tests; Protein Structure, Tertiary; Pyridines; Pyrimidines; Pyrroles; Receptor, Platelet-Derived Growth Factor alpha; Recombinant Fusion Proteins; Recurrence; Tyrosine | 2003 |
Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.
Topics: Adult; Biomarkers, Tumor; Cell Line, Tumor; Chromatography, High Pressure Liquid; Female; Humans; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nerve Growth Factors; Prognosis; Recurrence; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Time Factors; Tyrosine | 2003 |
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and th
Topics: Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Comorbidity; Coronary Disease; Female; Hospitalization; Humans; Life Tables; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Stents; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 2004 |
[Clinical observation on treatment of infantile repeated respiratory infection by combined use of heluo oral liquid and Astragalus].
Topics: Adjuvants, Immunologic; Astragalus Plant; Child; Child, Preschool; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Infant; Male; Nucleic Acids; Phytotherapy; Pneumonia; Recurrence; Respiratory Tract Infections; Tyrosine | 2004 |
Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
Topics: Adaptor Proteins, Signal Transducing; Adenoma; Adenomatous Polyposis Coli Protein; Alleles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Clathrin; Colorectal Neoplasms; Cyclooxygenase 2; Dinoprostone; Disease Progression; Enterocytes; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Genes, APC; HeLa Cells; Humans; Immunoblotting; Immunohistochemistry; Immunoprecipitation; Intestinal Mucosa; Intestine, Small; Isoenzymes; Jurkat Cells; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Mutation; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Recurrence; Signal Transduction; src-Family Kinases; Tissue Distribution; Transcriptional Activation; Tyrosine; Ubiquitin; Up-Regulation; Vanadates | 2004 |
Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
Topics: Genes, erbB-2; Genes, Reporter; Humans; Male; Neuregulin-1; Phosphorylation; Prostatic Neoplasms; Receptor, ErbB-2; Receptor, ErbB-3; Receptors, Androgen; Recurrence; Signal Transduction; Transcriptional Activation; Tumor Cells, Cultured; Tyrosine | 2005 |
Brain injury following repetitive apnea in newborn piglets.
Topics: Animals; Animals, Newborn; Apnea; Brain; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine; Neurons; Recurrence; Swine; Tyrosine | 2006 |
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis | 2006 |
Apoptosis bcl-2 and nitrotyrosine expression in an angioplasty-restenosis rabbit: an experimental model.
Topics: Angioplasty, Balloon; Animals; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Cell Movement; Cell Proliferation; Iliac Artery; Immunoenzyme Techniques; In Situ Nick-End Labeling; Male; Membrane Proteins; Muscle, Smooth, Vascular; Proto-Oncogene Proteins; Rabbits; Recurrence; Statistics, Nonparametric; Tyrosine | 2007 |
N-Acetyl-L-tyrosine ethyl ester (ATEe) hydrolytic activities of diseased human palatine tonsils. Possible pathogenesis of recurrent acute tonsillitis.
Topics: Acute Disease; Adolescent; Adult; Biopsy; Child; Child, Preschool; Complement C1s; Humans; Hydrolysis; Hypertrophy; Middle Aged; Palatine Tonsil; Recurrence; Tonsillitis; Tyrosine | 1984 |
[Clinical significance of various metabolic disorders in patients with chronic pancreatitis].
Topics: Chronic Disease; Fatty Acids, Nonesterified; Humans; Hyperlipidemias; Pancreatitis; Recurrence; Serotonin; Triglycerides; Tyrosine | 1984 |
In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET.
Topics: Adult; Brain; Brain Neoplasms; Carbon Radioisotopes; Female; Humans; Male; Middle Aged; Models, Biological; Protein Biosynthesis; Recurrence; Tomography, Emission-Computed; Tyrosine | 1995 |
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; Calcitonin; Carcinoma, Medullary; Cysteine; DNA; DNA Primers; DNA, Neoplasm; Drosophila Proteins; Exons; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Point Mutation; Polymerase Chain Reaction; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Recurrence; Restriction Mapping; Thyroid Neoplasms; Tyrosine | 1996 |
Evidence for the production of peroxynitrite in inflammatory CNS demyelination.
Topics: Acute Disease; Animals; Chronic Disease; Encephalomyelitis, Autoimmune, Experimental; Female; Immunohistochemistry; Mice; Mice, Inbred Strains; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Recurrence; Remission Induction; Serum Albumin, Bovine; Spinal Cord; Tyrosine | 1997 |
[Superaspirin in the platelet aggregation inhibitor therapy].
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine | 1997 |
Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris.
Topics: Angina, Unstable; Atherectomy, Coronary; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorylation; Receptors, Platelet-Derived Growth Factor; Recurrence; Regression Analysis; Risk Factors; Statistics, Nonparametric; Tyrosine | 1998 |
Peroxynitrite formation within the central nervous system in active multiple sclerosis.
Topics: Central Nervous System; Humans; Immunohistochemistry; Inflammation; Multiple Sclerosis; Nervous System Diseases; Nitrates; Nitrites; Recurrence; Tyrosine | 1998 |
The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque.
Topics: Aged; Carotid Arteries; Carotid Stenosis; Cytomegalovirus Infections; Female; Humans; Immunohistochemistry; In Situ Hybridization; Intracranial Arteriosclerosis; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Recurrence; Risk Factors; Tyrosine | 1999 |
Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats.
Topics: Angioplasty, Balloon; Animals; Aorta; Arteries; Carotid Arteries; Cell Division; Cell Survival; Cells, Cultured; Constriction, Pathologic; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Receptor, Platelet-Derived Growth Factor beta; Recurrence; Tunica Intima; Tyrosine; Tyrphostins; Up-Regulation | 2000 |
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris.
Topics: Adult; Age Distribution; Aged; Angina, Unstable; Coronary Angiography; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heparin; Humans; Male; Middle Aged; Myocardial Ischemia; Odds Ratio; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Probability; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sex Distribution; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention.
Topics: Abciximab; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Creatine Kinase; Drug Therapy, Combination; Eptifibatide; Female; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Immunoglobulin Fab Fragments; Length of Stay; Male; Middle Aged; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Recurrence; Retrospective Studies; Survival Rate; Tirofiban; Treatment Outcome; Tyrosine | 2001 |
Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis.
Topics: Dopamine; Female; Genetic Predisposition to Disease; Humans; Methamphetamine; Norepinephrine; Prisoners; Psychotic Disorders; Recurrence; Reference Values; Stress, Psychological; Substance-Related Disorders; Tyrosine | 2002 |
Opioid-reinforced operant behavior: selective suppression by alpha-methyl-para-tyrosine.
Topics: Administration, Oral; Animals; Benzimidazoles; Benzyl Compounds; Catecholamines; Conditioning, Operant; Depression, Chemical; Diethylamines; Dose-Response Relationship, Drug; Extinction, Psychological; Humans; Injections, Intraperitoneal; Isomerism; Male; Methyltyrosines; Milk; Morphine; Morphine Dependence; Motor Activity; Rats; Recurrence; Reinforcement Schedule; Reinforcement, Psychology; Substance Withdrawal Syndrome; Tyrosine; Water Deprivation | 1975 |
Tyrosinemia II: report of an incomplete case and studies on the hyperkeratotic stratum corneum.
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Amino Acids; Heel; Humans; Keratoderma, Palmoplantar; Male; Patient Compliance; Recurrence; Tyrosine | 1991 |
[Relation of the outcome of disk epiphysectomy in dysplastic scoliosis and the biochemical composition of the vertebral body].
Topics: Acetylglucosaminidase; Adolescent; Female; Galactosidases; Glucuronidase; Glycosaminoglycans; Humans; Hydroxyproline; Intervertebral Disc; Male; Recurrence; Scoliosis; Tensile Strength; Thoracic Vertebrae; Tyrosine | 1990 |
Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord.
Topics: Animals; Brain; Chronic Disease; Dopamine; Encephalomyelitis, Autoimmune, Experimental; Female; Hydroxyindoleacetic Acid; Neurotransmitter Agents; Norepinephrine; Rats; Recurrence; Serotonin; Spinal Cord; Tissue Distribution; Tryptophan; Tyrosine | 1986 |